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httpcense.Abstract Background: Because there are differences between the upper limb (UL) and lower limb
(LL) muscles in terms of the morphological and functional adaptations in COPD patients, speciﬁc
protocols for strength training and endurance should be developed and tested for the corresponding
muscle groups.
Aim: To elucidate the potential effects of unsupported UL and/or LL exercise training in
patients with COPD. The 6-min walking distance (6-MWD), unsupported upper limb endurance
(UULE) time, St. George’s Respiratory questionnaire (SGRQ), BODE index and pulmonary func-
tion tests are used as outcome measures.
Methods: A prospective, randomized controlled study of patients with COPD. Patients were ran-
domly assigned to one of 4 groups, group A received UL training, group B received LL training,
group C received both UL and LL training and group D received no training (controls). Patients
in group A, B, and C underwent exercise training 3 times weekly for 8 weeks. The outcome mea-
sures were carried out at study entry and after 8 weeks.
Results: 78 patients completed the study: 20 patients in group A, 21 in group B, 19 in group C
and 18 in group D. Upper limb training signiﬁcantly increased UULE time without affecting 6-
MWD while LL training signiﬁcantly increased 6-MWD without changing UULE time. Combined
UL and LL training signiﬁcantly increased both UULE time and 6-MWD. Signiﬁcant reductions in
the scores of SGRQ and BODE index were observed in groups A, B and C but not group D (con-
trol). No changes were found in pulmonary function in all groups at the end of the study.ulty of Medicine, Mansoura
l.: +20 01223836717.
ail.com (A.E. Mansour).
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90 A.S. Elmorsy et al.Conclusion: In patients with COPD, combined UL and LL training signiﬁcantly enhanced the
exercise tolerance and quality of life and reduced the risk of death (BODE index) without any
change in the pulmonary function.
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Systemic effects of COPD involve respiratory and skeletal
muscles with loss of myosin heavy chain and elevated level
of ubiquitin-conjugated proteins, suggesting accelerated mus-
cle protein degradation [1]. The remaining contractile proteins
in these ﬁbres are dysfunctional, and the calcium sensitivity of
force generation is reduced. These abnormalities could all con-
tribute to muscle weakness [1].
Although patients with COPD have been reported to pres-
ent with impaired lower limb (LL) and upper limb (UL) mus-
cles, the morphological and functional adaptations appear to
differ between these muscles. Celli et al. [2] were the ﬁrst to
compare LL and UL activities in patients with COPD showing
that unsupported UL activities in COPD ended before LL
exercises did. Patients with COPD frequently experience
marked dyspnea and fatigue when performing simple UL
activities [3]. Upper limb activities commonly require unsup-
ported arm exercise, which poses a unique challenge for pa-
tients with COPD, whose UL muscles are required to act as
accessory muscles of respiration. During unsupported arm
exercise, the participation of the accessory muscles in ventila-
tion decreases, and there is a shift of respiratory work to the
diaphragm. This is associated with thoracoabdominal dyssyn-
chrony, severe dyspnea, and termination of exercise at low
workloads [4]. Regarding the lower limbs, reduced muscle
strength and endurance are related to decreased muscle mass,
decreased aerobic capacity, a predominance of glycolytic
metabolism, and rapid accumulation of lactate during exercise,
factors that might be responsible for early muscle fatigue in
COPD patients [5].
The effectiveness of LL exercise training for patients with
COPD has been well documented, with consistent clinically
signiﬁcant improvements in exercise capacity, symptoms, and
quality of life [6]. Moreover; it has been seen that UL exercise
training for patients with COPD increases UL work capacity,
improves endurance, and reduces oxygen consumption at a gi-
ven workload [7–9]. The beneﬁts of combined UL and LL
training, however, are less well deﬁned. Therefore, the aim of
this study was to measure exercise performance, quality of life
and functional outcome by combining UL with LL exercises in
patients with COPD.
Patients and methods
The patients were selected based on the criteria of the Ameri-
can Thoracic Society (ATS) for COPD: a history of smoking,
X-ray ﬁndings, a medical history, and physical examination
consistent with the diagnosis of COPD. Pulmonary function
tests conﬁrmed irreversible airﬂow obstruction, as measured
by a forced expiratory volume in 1 s (FEV1) <80% of the pre-
dicted normal value [16] and a FEV1/forced vital capacity
(FVC) ratio <70%. All patients had a stable clinical condition
at the time of study. Patients with coexistent diseases, such ascardiovascular disease, diabetes, dementia, musculoskeletal
problems, or vision difﬁculty, were excluded.
Protocol
A prospective, randomized controlled trial. Patients were ran-
domly assigned to one of 4 groups, group A receiving UL
training, group B receiving LL training, group C receiving
both UL and LL training and group D receiving no exercise
training (control group). Patients in group A and B underwent
exercise training 3 times weekly for 8 weeks while patients in
group C had UL and LL exercise training on alternate days.
1. Upper limb exercise (30 min): This involved a 10-min
warm-up period, 10-min of aerobic activity and 10-min
cool-down. The aerobic activity included diagonal arm
raises, arm abduction and elevation and reverse, and arm
abduction, forward ﬂexion, and reverse; and straight arm
rises.
2. Lower limb exercise (30min): This involved a 10-min warm
up, 10-min of cycling on an ergometric bicycle and 10-min
cool down.
3. Combined upper and lower limbs exercise: This involved UL
and LL exercise training on alternate days using the same
protocols.Outcome assessment
The followings were measured just before enrollment and at
the end of the study:
1. Unsupported upper limb endurance (UULE) time: This was
measured as previously described [10]. In breif; the patient
was seated erect in a straight-backed chair with both feet on
the ﬂoor facing the wall on which a chart was mounted. The
chart consisted of eight horizontal colored strips of paper,
the distance between the centers of the strips was 0.15 m.
Each strip also had a clearly visible stage number. The ﬁrst
level was adjusted to be at the level of patient’s knees by
altering the position of the chart on the wall. The highest
level the patient could reach was recorded. The patient held
a light plastic bar (0.2 kg) and moved it during the exercise
test. The test began with the patients lifting the bar from a
neutral position to the ﬁrst level, then the vertical amplitude
of the lift increased by 0.15 m every minute as the patient
progressed through the stages of the test. Once the patient
reached maximum vertical height, the weight of the bar was
progressively increased by 0.5 kg every minute to a maxi-
mum weight of 2 kg. Heart rate, dyspnea, and partial oxy-
gen saturation were measured before and after the test. The
test was terminated if the patient experienced dyspnea or
arm fatigue at the maximum position reached. The endur-
ance time was recorded.
2. 6-minutes walking distance (6-MWD): This was conducted
in a hospital corridor as previously described [11]. During
the test the patient was instructed to walk as fast as possible
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riencing severe dyspnea or any other limiting discomfort.
Heart rate, dyspnea, and partial oxygen saturation were
measured before and after the test. A minimal clinically sig-
niﬁcant difference in 6-MWD in patients with COPD was
estimated to be 35 m [12].
3. Health-related quality of life: This was assessed by the St
George’s Respiratory Questionnaire (SGRQ) [13]. Each
component of the questionnaire gives a weighted score
between 0 and 100, including the total, with normal values
in healthy individuals of <7 for each component. A change
of 4 points in the total score has been shown to represent a
minimal clinically signiﬁcant change [14].
4. BODE index: It is an index including 4 factors to predict
the risk of death in COPD: the body mass index; BMI
(B), the degree of airﬂow obstruction (O), the dyspnea
(D), and exercise capacity (E) as assessed by the 6-MWD
[15].
5. Pulmonary function tests: FVC, FEV1, FEV1/FVC, RV and
TLC were measured using a computed unit (Jager, Ger-
many) according to ATS guidelines [16].
Statistical methods
Categorical data were presented as numbers (percentage) while
continuous variables were presented as mean (± standard
deviation). One way ANOVA and X2 were used to compare
continuous and categorical variables among groups respec-
tively. Paired t-test was used within each group to assess
whether a signiﬁcant change from baseline had occurred. A p
value <0.05 was considered signiﬁcant. Data were analyzed
with the Statistical Package for Social Sciences (SPSS, Chi-
cago, IL).Table 1 Patients characteristics.
Group A (n= 20) B (n= 21)
Age (years) 62 ± 12 59 ± 8
Males 18 (90%) 19 (90%)
BMI (kg/m2) 24.2 ± 3.8 25.4 ± 4.2
BMI: body mass index.
a One way ANOVA.
b Chi square.
Table 2 Changes in outcome measures at the end of the study.
Group A (n= 20) B (n= 21)
Pre Post P Pre Post
UULE (seconds) 221 ± 41 265 ± 33 0.03 231 ± 54 228 ± 61
6-MWD (meters) 259 ± 12 266 ± 17 0.6 268 ± 16 323 ± 17
SGRQ 42 ± 2.8 31 ± 3.1 0.01 38 ± 4.3 29 ± 2.5
BODE 6 ± 0.43 4 ± 0.39 0.04 7 ± 0.37 5 ± 0.5
FEV1% 43 ± 2.3 45 ± 3.4 0.6 46 ± 4.1 48 ± 3.9
FVC% 77 ± 14.2 79 ± 15.8 0.2 81 ± 17.2 79 ± 11.
RV% 161 ± 2.9 163 ± 4.2 0.6 157 ± 3.5 160 ± 5.3
UULE: unsupported upper limb endurance time, 6-MWD: 6-min walk
BODE: BODE index, FEV1: forced expiratory volume in one second, FVResults
Patients characteristics (Table 1)
Patients’s age, gender, and BMI did not show any signiﬁcant
difference among the groups.
Outcome measures (Table 2)
There were no signiﬁcant differences among the groups at
baseline for any of the outcome variables.
1. The unsupported upper limb endurance time: The UULE
time increased signiﬁcantly after UL and combined training
but not LL training nor in controls.
2. 6-minutes walk distance: The 6-MWD increased signiﬁ-
cantly after LL and combined training but not UL training
nor in controls.
3. SGRQ total score: A signiﬁcant reduction in the total score
of SGRQ was observed in the training groups i.e. A, B and
C but not the control group (D).
4. BODE index: A signiﬁcant decrease in the score of BODE
index was observed in the training groups but not the con-
trol group.
5. Pulmonary function tests: No signiﬁcant changes were
observed in the parameters of the pulmonary function mea-
sured in all groups.
Discussion
This study shows that a physical exercise program designed to
strengthen LL and UL muscles improves the exercise toler-C (n= 19) D (n= 18) P value
67 ± 6 60 ± 11 0.68a
17 (89%) 16 (89%) 0.87b
23.7 ± 6.1 24.9 ± 4.9 0.16a
C (n= 19) D (n= 18)
P Pre Post P Pre Post P
0.4 213 ± 39 257 ± 51 0.03 222 ± 46 230 ± 38 0.3
0.02 266 ± 21 324 ± 23 0.05 273 ± 19 281 ± 22 0.4
0.02 37 ± 4.7 26 ± 3.1 0.01 43 ± 3.7 45 ± 3.9 0.7
4 0.04 6 ± 0.44 4 ± 0.41 0.05 7 ± 0.65 6 ± o.71 0.6
0.4 41 ± 3.7 43 ± 2.1 0.4 45 ± 3.5 45 ± 4.8 0.6
1 0.5 83 ± 6.3 81 ± 4.5 0.4 80 ± 9.8 79 ± 6.1 0.7
0.6 158 ± 4.9 158 ± 5.1 0.8 167 ± 2.5 162 ± 3.6 0.6
distance, SGRQ: total score of St. George respiratory questionaire,
C: forced vital capacity, RV: residual volume.
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out affecting the pulmonary function parameters.
The 6-MWD improved signiﬁcantly following exercise train-
ing of LL. Minimal clinically signiﬁcant difference in
6-MWD is deﬁned as the smallest meaningful change, judged
by the patient or experts, determined by questioning or observ-
ing the patient [17]. A recent analysis [12] of the interpretation of
change in 6-MWD in patients with moderate-to-severe COPD
(mean FEV1, 39.2 ± 14.1%) comes from pooled data from 9
prospective trials. Using 3 statistical methods, they estimated
a signiﬁcant change in 6-MWD as 35 m, corresponding to a
change of 10% from baseline 6-MWD. In this study, the mean
change of 6-MWD was 55 and 58 m in group B and C, respec-
tively. Limitation of exercise capacity is a hallmark of disability
in COPD and is associated with poor health-related quality of
life, increased morbidity, and higher mortality. [18–21]. Our
data suggest that LL strengthening effectively improved exer-
cise capacity as measured by 6-MWD. These ﬁndings are in
agreement with several previously published studies of patients
with COPD who received pulmonary rehabilitation [18,22–25].
The 6-MWD remained unchanged after UL training. Lake et al.
[9], compared UL training with LL training and found that UL
training improved arm function, but LL capacity was even
decreased in that group; LL training and combined training in-
creased 6-MWD. These ﬁndings could be explained by the fact
that training effect is speciﬁc for the muscle group trained, with
no cross-over beneﬁt seen between the arms and legs [9]. Knox
et al. [11], demonstrated a signiﬁcant improved result on the re-
peated performance of a 6-MWDover a 4-week period that was
mainly due to aerobic training effects and speciﬁcity of training.
The present study showed an improvement in UULE time
after UL training, which is in accordance with study done by
Epstein et al., who found that arm training resulted in in-
creased UL endurance [26]. This might be due to improved
synchronization and coordination of accessory muscle action
during unsupported arm activity [27].
A signiﬁcant reduction in the total score of SGRQ was ob-
served in the groups A, B and C but not group D. The SGRQ
has the advantage of being a standardized questionnaire,
allowing comparison between studies and different interven-
tions. A change of 4 points in the total score has been shown
to represent the minimal clinically signiﬁcant change [14]. Thus
in our study, a reduction of the total score of >4 points at the
end of 8 weeks clearly represents clinically signiﬁcant beneﬁts
from our training. These ﬁndings are consistent with those ob-
served by Grifﬁths et al. [28] where a mean improvement in to-
tal SGRQ score of 9.4 points was observed at 6 weeks, that
remained signiﬁcant at 4.8 points one year after an outpatient
rehabilitation program. The reduction of the total score of
SGRQ was mainly due to improvement of the dyspnea do-
main. This improvment in the dyspnea domain might be due
to the psychological beneﬁts of exercise, which included in-
creased motivation, desensitization to dyspnea [29] and loss
of fear of exercise.
A signiﬁcant decrease was noted in the score of BODE in-
dex in groups A, B and C but not D (control). This index is
useful being able to quantify the degree of pulmonary impair-
ment (FEV1), patients’ perception of dyspnea (that predicts the
likelihood of survival) [30], and the systemic consequences of
COPD (6-MWD and BMI). These data are in agreement with
the ﬁndings of Barakat et al. where a decrease of 2 points(from 6 to 4) was noted in the score of the BODE index after
UL and LL training [31].
The lack of changes in lung function parameters after train-
ing is not surprising. Reviewing the literature revealed that aer-
obic physical training did not modify lung function [6,29]. The
FVC of an individual is dependent on lung elastic recoil, chest
wall elasticity and respiratory muscle ﬁtness. Exercises in our
study are not designed to improve respiratory muscle stretch-
ing and have no effect on lung tissue structure.Conclusion
Our study showed that UL and LL exercise training in COPD
patients achieved a clinically signiﬁcant increase in health-re-
lated quality of life and exercise tolerance and a decrease in
the risk of death as measured using BODE index without
any changes in the pulmonary function.References
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